Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study

@article{Gartner2007AssessmentOS,
  title={Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study},
  author={Coral E. Gartner and Wayne D. Hall and Theo Vos and Melanie Y Bertram and Angela L. Wallace and Stephen S. Lim},
  journal={The Lancet},
  year={2007},
  volume={369},
  pages={2010-2014}
}

Tables from this paper

Tobacco Harm Reduction in the real world: has the availability of snus in Norway increased smoking cessation?

The quit rate for smoking is consistently observed to be higher for snus users than for smokers who have no experience of use of snus, and those using snus are more likely to have quit smoking completely or considerably reduce their use of cigarettes.

Patterns of Smoking and Snus Use in Sweden: Implications for Public Health

The availability and use of snus has been a major factor behind Sweden’s record-low prevalence of smoking and the lowest level of tobacco-related mortality among men in Europe, and when used subsequent to smoking, appears to facilitate smoking cessation.

Quantifying the effects of promoting smokeless tobacco as a harm reduction strategy in the USA

Promoting smokeless tobacco as a safer alternative to cigarettes is unlikely to result in substantial health benefits at a population level, according to a Monte Carlo simulation of a decision tree model of tobacco initiation and use.

Should the Health Community Promote Smokeless Tobacco (Snus) as a Harm Reduction Measure?

In the interests of promoting debate, the authors have agreed to outline the strongest arguments for and against promoting Swedish snus as a form of harm reduction.

Patterns of snus and cigarette use: a study of Norwegian men followed from age 16 to 19

Young men who only used snus at baseline had an increased risk of being dual users at follow-up, and snus use may therefore facilitate smoking.

Snus: a compelling harm reduction alternative to cigarettes

Prevalence statistics and epidemiological data indicate that the use of snus confers a significant harm reduction benefit which is reflected in the comparatively low levels of tobacco-related disease in Sweden when compared with the rest of Europe.

Should Australia lift its ban on low nitrosamine smokeless tobacco products?

There is a case on public health and ethical grounds for allowing inveterate smokers who want to reduce their health risks to access snus, and the recent increase in tax on smokeless tobacco should be reversed and the ban on the commercial importation and supply of low nitrosamine smokeless Tobacco should be reconsidered in light of the epidemiological evidence.

Switching to smokeless tobacco as a smoking cessation method: evidence from the 2000 National Health Interview Survey

Switching to ST compares very favorably with pharmaceutical nicotine as a quit-smoking aid among American men, despite the fact that few smokers know that the switch provides almost all of the health benefits of complete tobacco abstinence.

Harm perception among Swedish daily smokers regarding nicotine, NRT-products and Swedish Snus

Public information about smoking and health should be expanded to include objective and unambiguous information regarding nicotine's part in the harmfulness of smoking and the harmfuls of different nicotine-containing products compared to smoking in order to preclude that misperceptions regarding these matters could discourage smokers from adopting effective cessation practices.
...

References

SHOWING 1-10 OF 37 REFERENCES

Effect of smokeless tobacco (snus) on smoking and public health in Sweden

Snus availability in Sweden appears to have contributed to the unusually low rates of smoking among Swedish men by helping them transfer to a notably less harmful form of nicotine dependence.

Tobacco harm reduction: an alternative cessation strategy for inveterate smokers

There is a strong scientific and medical foundation for tobacco harm reduction, and it shows great potential as a public health strategy to help millions of smokers.

Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction

This issue of Tobacco Control considers the value of adding harm reduction products to the main public health strategies for dealing with tobacco use—prevention, cessation, and protection of non-smokers from tobacco smoke pollution.

Role of snus in initiation and cessation of tobacco smoking in Sweden

Use of snus in Sweden is associated with a reduced risk of becoming a daily smoker and an increased likelihood of stopping smoking.

Chronic disease mortality in a cohort of smokeless tobacco users.

Combined use of smokeless tobacco and cigarettes did not increase overall mortality beyond that expected from use of the individual products.

An alternative approach to smoking control.

  • B. Rodu
  • Medicine
    The American journal of the medical sciences
  • 1994
The author describes the magnitude of the health risks related to various forms of tobacco use and proposes that smokeless tobacco be recommended as a cigarette substitute by persons who cannot stop smoking.

Clearing the smoke: assessing the science base for tobacco harm reduction.

This chapter discusses the development of principles for Regulating Potential Reduced-Exposure Products and their applications in the context of Tobacco Harm Reduction.

The prospects for tobacco harm reduction

  • W. Hall
  • Medicine, Political Science
  • 2005

Estimate of deaths attributable to passive smoking among UK adults: database analysis

Exposure at work might contribute up to one fifth of all deaths from passive smoking in the general population aged 20-64 years, and up to half of such deaths among employees of the hospitality industry.